Skip to main navigation
Skip to search
Skip to main content
Projects and Grants
Press / Media
Fellowships, Honors, and Prizes
A phase 1, open-label dose-escalation study of SEA-CD40 in adult patients with advancedmalignancies
Medicine - Hematology, Oncology, Transplant
A phase 1, open-label dose-escalation study of SEA-CD40 in adult patients with advanced malignancies
Effective start/end date
Seattle Genetics, Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Medicine & Life Sciences